Increased Body Iron Stores of Obese Women With Polycystic Ovary Syndrome Are a Consequence of Insulin Resistance and Hyperinsulinism and Are Not a Result of Reduced Menstrual Losses

作者: M. Luque-Ramirez , F. Alvarez-Blasco , J. I. Botella-Carretero , R. Sanchon , J. L. San Millan

DOI: 10.2337/DC07-0642

关键词:

摘要: OBJECTIVE —Increased serum ferritin levels, indicating increased body iron stores, have been found in overweight and obese women with polycystic ovary syndrome (PCOS). This finding might result from reduced menstrual losses secondary to oligo- or amenorrhea hyperinsulinism insulin resistance, because favors the intestinal absorption tissue deposition of iron. To explore which these mechanisms is responsible for increase stores PCOS, we monitored changes levels during treatment an antiandrogenic oral contraceptive sensitizer. RESEARCH DESIGN AND METHODS —Thirty-four consecutive PCOS patients were randomized containing 35 μg ethinyl-estradiol plus 2 mg cyproterone acetate (Diane Diario) metformin (850 twice daily), their evaluated at baseline after 12 24 weeks treatment. RESULTS —Despite fact that Diane Diario restored regular cycles all patients, whereas only did so 50% them, decreased metformin, association a marked sensitivity. On contrary, no sensitivity observed Diario. CONCLUSIONS —Our present results suggest resistance hyperinsulinism, not amenorrhea, are PCOS.

参考文章(34)
Stephen Franks, Polycystic ovary syndrome. The New England Journal of Medicine. ,vol. 333, pp. 853- 861 ,(1995) , 10.1056/NEJM199509283331307
J. M. Fernandez-Real, G. Penarroja, A. Castro, F. Garcia-Bragado, A. Lopez-Bermejo, W. Ricart, Blood Letting in High-Ferritin Type 2 Diabetes: Effects on vascular reactivity Diabetes Care. ,vol. 25, pp. 2249- 2255 ,(2002) , 10.2337/DIACARE.25.12.2249
J. I. Botella-Carretero, M. Luque-Ramirez, F. Alvarez-Blasco, J. L. San Millan, H. F. Escobar-Morreale, Mutations in the Hereditary Hemochromatosis Gene Are Not Associated With the Increased Body Iron Stores Observed in Overweight and Obese Women With Polycystic Ovary Syndrome Diabetes Care. ,vol. 29, pp. 2556- 2556 ,(2006) , 10.2337/DC06-1655
Manuel Luque-Ramírez, Francisco Álvarez-Blasco, José I. Botella-Carretero, Elena Martínez-Bermejo, Miguel A. Lasunción, Héctor F. Escobar-Morreale, Comparison of Ethinyl-Estradiol Plus Cyproterone Acetate Versus Metformin Effects on Classic Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome The Journal of Clinical Endocrinology and Metabolism. ,vol. 92, pp. 2453- 2461 ,(2007) , 10.1210/JC.2007-0282
R. Taylor, D. J. Husband, S. M. Marshall, W. M. G. Tunbridge, K. G. M. M. Alberti, Adipocyte insulin binding and insulin sensitivity in ‘brittle’ diabetes Diabetologia. ,vol. 27, pp. 441- 446 ,(1984) , 10.1007/BF00273908
D. A. Ehrmann, R. B. Barnes, R. L. Rosenfield, M. K. Cavaghan, J. Imperial, Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. ,vol. 22, pp. 141- 146 ,(1999) , 10.2337/DIACARE.22.1.141
Robert C. Cooksey, Hani A. Jouihan, Richard S. Ajioka, Mark W. Hazel, Deborah L. Jones, James P. Kushner, Donald A. McClain, Oxidative stress, β-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis Endocrinology. ,vol. 145, pp. 5305- 5312 ,(2004) , 10.1210/EN.2004-0392
C. Niederau, M. Berger, W. Stremmel, A. Starke, G. Strohmeyer, R. Ebert, E. Siegel, W. Creutzfeldt, Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia. ,vol. 26, pp. 441- 444 ,(1984) , 10.1007/BF00262217
Ricardo Azziz, Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature The Journal of Clinical Endocrinology and Metabolism. ,vol. 91, pp. 781- 785 ,(2006) , 10.1210/JC.2005-2153
Guillaume Le Guenno, Emilie Chanséaume, Marc Ruivard, Béatrice Morio, Andrzej Mazur, Study of iron metabolism disturbances in an animal model of insulin resistance Diabetes Research and Clinical Practice. ,vol. 77, pp. 363- 370 ,(2007) , 10.1016/J.DIABRES.2007.02.004